Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia

European Psychiatry

Volumn 22, Issue 8, 2007, Pages 499-504

  Prikryl, Radovan ^a   Ceskova, Eva ^a   Kasparek, Tomas ^a   Kucerova, Hana ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

First episode; Neurology; Schizophrenia; Soft signs

Indexed keywords

AMISULPRIDE; HALOPERIDOL; OLANZAPINE; OXYPROTHEPINE DECANOATE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR COORDINATION; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM;

ADULT; ANTIPSYCHOTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 36049037188     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.03.012     Document Type: Article

References (29)

1. Andreasen N.C., Carpenter Jr. W.T., Kane J.M., Lasse R.A., Marder S.R., and Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162 (2005) 441-449
2. Bachman S., Bottmer C.H., and Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 162 (2005) 2337-2343
3. Browne S., Clarke M., Gervin M., Lane A., Waddington J.L., Larkin C., et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med 30 (2000) 1433-1441
4. Buchanan R.W., and Heinrichs D.W. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs of schizophrenia. Psychiatry Res 27 (1989) 335-350
5. Buchanan R.W., Koeppl P., and Brier A. Stability of neurological signs with clozapine treatment. Biol Psychiatry 36 (1994) 198-200
6. Chen E.Y., Hui C.H.L., Chan R.C.H., Dunn E.L., Miao M.Y., Yeung W.S., et al. A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophr Res 75 (2005) 45-54
7. Dazzan P., Morgan K.D., Orr K.G., Hutchinson G., Chitnis X., Suckling J., et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 127 (2004) 143-153
8. Dazzan P., and Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 43 (2002) 50-57
9. Emsley R., Turner H.J., Oosthuizen P.P., and Carr J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophr Res 75 (2005) 35-44
10. Gupta S., Andreasen N.C., Arndt S., Flaum M., Schultz S.K., Hubbard W.C., et al. Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry 152 (1995) 191-196
11. Griffiths T.D., Sigmundsson T., and Takei N. Neurological abnormalities in familiar and sporadic schizophrenia. Brain 121 (1998) 191-203
12. Heinrichs D.W., and Buchanan R.W. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 145 (1988) 528-537
13. International Statistical Classification of Diseases and Related Health Problems, 1989 Revision (1992), World Health Organization, Geneva
14. Johnstone E.C., Macmillan J.F., Frith C.D., Bennm D.K., and Crow T.J. Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 157 (1990) 182-189
15. Kay S., Fiszbein A., and Opler L.A. The positive and negative syndrome scale for schizophrenia. Schizophr Bull 13 (1987) 261-278
16. Keshavan M.S., Sanders R.D., Sweeney J.A., Diwadkar V.A., Goldstein G., Pettegrew J.W., et al. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 160 (2003) 1298-1304
17. Kucerova H., Prikryl R., Spacek J., Kasparek T., and Ceskova E. Neurologické mekke priznaky a kognitivni dysfunkce u schizofrenie. Psychiatrie. časopis pro moderní psychiatrii supplementum 2 (2003) 51-53
18. Madsen A.L., Vorstrup S., and Rubin P. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand 100 (1999) 119-125
19. Ovsiew F. Bedside neuropsychiatry: eliciting the clinical phenomena of neuropsychiatric illness. In: Yudovsky S.C., and Hales R.E. (Eds). Synopsis of Neuropsychiatry (1994), American Psychiatric Press, Washington, DC 77-106
20. Prikryl R., Ceskova E., Kasparek T., and Kucerova H. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. J Psychiatr Res 40 (2006) 141-146
21. Rubin P., Vostrup S., Hemmingsen R., Andersen H.S., Bendsen B.B., Strømsø N., et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlation with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr Scand 90 (1994) 385-390
22. Sanders R.D., Keshavan M.S., and Schooler N.R. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry 151 (1994) 1231-1233
23. Schroder J., Niethammer R., Geider F.J., Reitz C., Binkert M., Jauss M., et al. Neurological soft signs in schizophrenia. Schizophr Res 6 (1992) 25-30
24. Smith R.C., and Kadewari R.P. Neurological soft signs and response to risperidone in chronic schizophrenia. Biol Psychiatry 40 (1996) 1056-1059
25. Smith R.C., Hussain M.I., and Chowdhury S.A. Stability of neurological soft signs in chronically hospitalized schizophrenic patients. J Neuropsychiatry Clin Neurosci 11 (1996) 91-96
26. Torrey E.G. Neurological abnormalities in schizophrenic patients. Biol Psychiatry 15 (1980) 381-388
27. Tucker G.J., and Silberfarb P.M. Neurologic dysfunction in schizophrenia: significance for diagnostic practice. In: Akistal H., and Webb W. (Eds). Psychiatric Diagnosis: Exploration of Biological Predictors (1978), Spektrum, New York 453-462
28. Whitty P., Clarke M., Browne S., McTigue O., Kamali M., Feeney L., et al. Prospective evaluation of neurological soft signs in first episode-schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol Med 33 (2003) 1479-1484
29. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (2003) 663-667